[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

2015-2019 U.S. Drugs of Abuse POC/Point-of-Care Testing Market: Physician Offices, Emergency Rooms, Ambulatory Care Centers - Supplier Shares, Sales Forecasts, Emerging Technologies, Competitive Strategies

September 2015 | 165 pages | ID: 2874B419E9FEN
Venture Planning Group

US$ 2,000.00 US$ 2,500.00 -20 %

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This new 165-page report from VPGMarketResearch contains 14 tables, and provides a comprehensive analysis of thePOC drugs of abuse testing market, including trends, dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. This report will help diagnostic product suppliers develop effective business, R&D and marketing strategies for the global POC abused drugs market. RationaleThe growing economic pressures on hospitals, coupled with advances in diagnostic technologies, intensifying competition among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals and commercial laboratories closer to the patient.

Market Segmentation Analysis

Review of three POC market segments, including their dynamics, trends, structure, size, growth and major suppliers. - Five-year test volume and reagent sales forecasts for drugs of abuse procedures by market segment:- Physician Offices/Group Practices- Emergency Rooms - Ambulatory Care Centers- Analysis of drugs of abuse procedures Competitive Assessments- Assessments of major POC suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, joint ventures, and new products in R&D. Strategic Recommendations- Specific opportunities for new instruments and reagent systems with potentially significant market appeal during the next five years. - Design criteria for POC testing products. - Alternative business expansion strategies.
  • Potential market entry barriers and risks. MethodologyThis report is based on a combination of primary and secondary sources of information, including review of the latest technical and business publications, manufacturer product literature, industry analyst reports, and VPGMarketResearch's proprietary data files. Contains 165 pages and 14 tables
  • INTRODUCTION

    EXECUTIVE SUMMARY

    RATIONALE FOR TESTING DECENTRALIZATION
      1. OVERVIEW
      2. REGULATORY TRENDS
      3. ECONOMIC TRENDS
      4. DEMOGRAPHIC TRENDS
      5. TECHNOLOGICAL TRENDS
      6. SOCIAL TRENDS
      7. QUALITY OF CARE
      8. DEFENSIVE MEDICINE
      9. QUALITY CONTROL ISSUES
    Lipid Test: Significance and Diagnostic Procedures
      1. CHOLESTEROL
      2. HIGH-DENSITY LIPOPROTEIN (HDL)
      3. LOW-DENSITY LIPOPROTEIN (LDL)
      4. TRIGLYCERIDES
    POC Testing INSTRUMENTATION
      Abaxis
      Abbott
      Alfa Wassermann
      Awareness Technologies
      Beckman Coulter/Danaher
      bioMeriuex
      Carolina Chemistries
      Horiba
      Inverness
      Medica
      Nova Biomedical
      Ortho-Clinical Diagnostics
      Polimedco
      Randox
      Roche
    CURRENT AND EMERGING TECHNOLOGIES
      1. MONOCLONAL ANTIBODIES
      2. IMMUNOASSAYS
        a. Technological Principle
        b. Enzyme Immunoassays (EIA)
          Overview
          ELISA
          Dot Immunobinding Assays
          Capillary Immunoassays
          Particle-Membrane Capture Immunoassay
          Enzyme Amplification
        c. Fluorescent Immunoassays
          Fluorescent Polarization
          Time-Resolved Pulse Fluorescence
        d. Luminescence
          Chemiluminescence
          Bioluminescence
        e. Latex Agglutination
        f. Immunoprecipitation
      3. DRY CHEMISTRY
      4. BIOSENSORS
      5. IT AND AUTOMATION

    U.S.A.

    A. Market Overview
      1. BUSINESS ENVIRONMENT
        a. Health Care Expenditures
        b. Cost Consciousness
        c. Reimbursement
        d. Industry Consolidation
        e. Managed Care
          PPO
          HMO
        f. Hospitals
        g. Admissions
        h. Length of Stay
        i. Industry Diversification
        j. Physician Demographics
        k. Aging Population
          More Chronic Illness
          Disease Incidence
          Susceptibility to latrogenesis
          Multiple Illnesses Cases
        l. Laboratory Regulations
      2. MARKET STRUCTURE
        a. Hospitals
        b. Commercial/Private Laboratories
    B. Physician Offices/Group Practices
      1. MARKET SUMMARY
      2. MARKET STRUCTURE
      3. TEST VOLUME AND SALES FORECASTS
    C. Emergency Departments
        a. Market Summary
        b. Test volume and Sales Forecasts
      4. ICUS/CCUS
        a. Market Summary
        b. Test Volume and Sales Forecast
    D. Ambulatory Care Centers
      1. INTRODUCTION
      2. MARKET SUMMARY
      3. MARKET STRUCTURE
      4. TEST VOLUME AND SALES FORECASTS
    E. Major Suppliers’ Market Shares

    Germany

    A. Market Overview
    B. Market Structure
    C. Market Summary
    D. Test Volume and Sales Forecasts
    E. Major Suppliers’ Market Shares
    Spain A. Business Environment
    B. Market Structure
    C. Market Summary
    D. Test Volume and Sales Forecasts
    E. Major Suppliers’ Market Shares

    DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS

    ALTERNATIVE MARKET PENETRATION STRATEGIES

    A. Internal Development
    B. Collaborative Arrangements
    C. University Contracts
    D. Distribution Strategies for Decentralized Testing Markets
      1. MARKETING APPROACHES
      2. PRODUCT COMPLEXITY
      3. CUSTOMER PREFERENCE
      4. ESTABLISHED SUPPLIERS
      5. EMERGING SUPPLIERS
      6. MAJOR TYPES OF DISTRIBUTORS
      7. MARKET SEGMENTATION

    POTENTIAL MARKET ENTRY BARRIERS AND RISKS

    A. Market Maturity
    B. Cost Containment
    C. Competition
    D. Technological Edge and Limitations
    E. Patent Protection
    F. Regulatory Constraints
    G. Decentralized Testing Market Challenges

    COMPANY PROFILE

    Abbott
    ADI/American Diagnostica
    Agilent Technologies
    Alere/Biosite/Inverness
    Axis-Shield
    Beckman Coulter/Danaher
    Becton Dickinson
    Bio/Data
    Biomerieux
    Bio-Rad
    Cepheid
    Chrono-Log
    Corgenix
    Decode Genetics
    Diadexus
    Diagnocure
    Diagnostica Stago/Trinity Biotech
    Diamedix
    Diasorin
    Eiken Chemical
    EKF Diagnostics
    Fujirebio
    Grifols
    Helena Laboratories
    Hologic/Gen-Probe
    Horiba
    INSTRUMENTATION Laboratory
    International Technidyne/Nexus DX
    Kreatech/Leica
    Kyowa Medex
    Lonza
    Mackay Life Sciences
    Matritech
    Nihon Kohden
    Ortho-Clinical Diagnostics
    Polartechnics
    Polymedco
    Qiagen
    Roche
    SDIX
    Sequenom
    Siemens
    Sienco
    Sysmex
    Takara Bio
    ThermoFisher
    Tosoh
    Wako
    Zycare/Alere

    LIST OF TABLES

    Major Companies Developing or Marketing Cholesterol Tests
    Major Companies Developing or Marketing HDL Tests
    Major Companies Developing or Marketing Triglycerides Tests
    U.S.A., Office-Based Physicians Forecast by Practice Type
    U.S.A., Physician Offices/Group Practices Forecast by Type
    U.S.A., Physician Office/Group Practice Laboratories Forecast by Practice Size
    U.S.A., Physician Offices/Group Practices Lipid Test Volume Forecast
    U.S.A., Physician Offices/Group Practices Lipid Tests Reagent Market Forecast
    U.S.A., Ancillary Hospital Locations Estimated Number
    U.S.A., Ancillary Hospital Locations Annual Utilization
    U.S.A., Hospital Emergency Departments Lipid Test Volume Forecast
    U.S.A., Hospital Emergency Departments Lipid Test Reagent Market Forecast
    U.S.A., Ambulatory Care Centers Estimated Number of Facilities and Patient Visits
    U.S.A., Ambulatory Care Centers Most Frequent Diagnoses
    U.S.A., Ambulatory Care Centers Lipid Test Volume Forecast
    U.S.A., Ambulatory Care Centers Lipid Test Reagent Market Forecast
    U.S.A., Major Suppliers of Clinical Chemistry Diagnostic Products, Estimated Market Shares
    U.S.A., Major Suppliers of Clinical Chemistry Reagents, Estimated Market Shares
    U.S.A., Major Suppliers of Clinical Chemistry Analyzers, Estimated Market Shares
    U.S.A., Major Suppliers of Immunodiagnostic Products, Estimated Market Shares
    U.S.A., Major Suppliers of Immunoassay Reagents, Estimated Market Shares
    U.S.A. Major Suppliers of Immunoassay Analyzers, Estimated Market Shares
    Germany, Laboratory Performing Diagnostic Tests
    Germany, Physician Offices/Group Practices Lipid Test Volume Forecast
    Germany, Physician Offices/Group Practices Lipid Test Reagent Market Forecast
    Germany, Major Suppliers of Clinical Chemistry Diagnostic Products, Estimated Market Shares
    Germany, Major Suppliers of Clinical Chemistry Reagents, Estimated Market Shares
    Germany, Major Suppliers of Clinical Chemistry Analyzers, Estimated Market Shares
    Germany, Major Suppliers of Immunodiagnostic Products, Estimated Market Shares
    Germany, Major Suppliers of Immunodiagnostic Reagents, Estimated Market Shares
    Germany, Major Suppliers of Immunoassay Analyzers, Estimated Market Shares
    Spain, Laboratory Performing Chemistry and Immunoassay Tests
    Spain, Ambulatory Care Centers Lipid Test Volume Forecast
    Spain, Ambulatory Care Centers Lipid Test Reagent Market Forecast
    Spain, Major Suppliers of Clinical Chemistry Diagnostic Products, Estimated Market Shares
    Spain, Major Suppliers of Immunodiagnostic Products, Estimated Market Shares


    More Publications